ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Channel Therapeutics Corporation

Channel Therapeutics Corporation (CHRO)

0.66
-0.1749
( -20.95% )
Updated: 13:25:05

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.66
Bid
-
Ask
-
Volume
90,885
0.65 Day's Range 0.7899
0.45 52 Week Range 6.00
Market Cap
Previous Close
0.8349
Open
0.7899
Last Trade
100
@
0.66
Last Trade Time
13:23:08
Financial Volume
$ 65,577
VWAP
0.721534
Average Volume (3m)
159,745
Shares Outstanding
6,028,011
Dividend Yield
-
PE Ratio
-0.54
Earnings Per Share (EPS)
-1.22
Revenue
-
Net Profit
-7.38M

About Channel Therapeutics Corporation

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Reno, Nevada, USA
Founded
-
Channel Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CHRO. The last closing price for Channel Therapeutics was $0.83. Over the last year, Channel Therapeutics shares have traded in a share price range of $ 0.45 to $ 6.00.

Channel Therapeutics currently has 6,028,011 shares outstanding. The market capitalization of Channel Therapeutics is $5.03 million. Channel Therapeutics has a price to earnings ratio (PE ratio) of -0.54.

CHRO Latest News

Chromocell Announces Amendment to Stock Repurchase Plan

FREEHOLD, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

Chromocell to Participate in the Virtual Investor Lunch Break Series

FREEHOLD, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024

FREEHOLD, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

Chromocell Issues Letter to Stockholders from Chief Executive Officer

FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

FREEHOLD, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

FREEHOLD, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.03695.922002888780.62310.880.55132737120.79810301CS
40.034.76190476190.630.880.45969120.75423293CS
12-0.28-29.78723404260.941.110.451597450.79197036CS
26-0.83-55.70469798661.491.750.45885490.83686472CS
52-5.34-89660.45640071.11864615CS
156-5.34-89660.45640071.11864615CS
260-5.34-89660.45640071.11864615CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
YINNDirexion Daily FTSE China Bull 3X Shares
$ 36.9947
(27.52%)
24.65M
PMNTPerfect Moment Ltd
$ 1.5794
(27.36%)
107.2k
HCWCHealthy Choice Wellness Corp
$ 1.50
(22.95%)
251.91k
CWEBDirexion Daily Csi China Internet Index Bull 2x Shares
$ 43.44
(22.23%)
1.45M
XPPProShares Ultra FTSE China 50
$ 22.17
(18.18%)
68.06k
YANGDirexion Daily FTSE China Bear 3X Shares New
$ 54.87
(-27.56%)
5.18M
CHROChannel Therapeutics Corporation
$ 0.66
(-20.95%)
95.21k
FXPProShares UltraShort FTSE China 50
$ 15.41
(-18.28%)
54.17k
UAMYUnited States Antimony Corp
$ 1.65
(-13.16%)
17.87M
ETHU2x Ether ETF
$ 10.96
(-11.11%)
22.64M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
$ 1.02
(7.05%)
338.62M
FXIiShares China Large Cap
$ 33.615
(9.25%)
88.39M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 29.45
(-0.54%)
39.57M
KWEBKraneShares CSI China Internet
$ 34.545
(11.11%)
37.47M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
$ 3.2901
(3.95%)
33.01M

Discussion

View Full Feed
lovethatgreen lovethatgreen 4 minutes ago
No surprise about more sprint meetings the idea was made clear last update.

Still no mention concerning the q paragraph about se Asia trials

No f... excuse

None
RDGL
tapioca tapioca 4 minutes ago
I think it’s safe to say this is P&D, ugly
HMBL
resx18 resx18 4 minutes ago
Edward Vakser, CEO of AURI commented: “We are very pleased with the latest results
of the 2024 surface prospecting program which have now led to the discovery of 3 very
prospective areas on the property.”
AURI
mankind mankind 5 minutes ago
CRNT paid up this am $4.94 for a new position. 400% increase in avg volume speaks volumes for me. Looks cheap based on last qtr eps. Comps look like easy beats if current qtr is sustainable. Looks like a double from here imo. Insiders have skin in the game, which is always nice to see.
CRNT
resx18 resx18 5 minutes ago
There are places that can help traders learn how to trade better/smarter $AURI
AURI
linkvest linkvest 5 minutes ago
Not sure if you convinced any flippers out there LOL.
RDAR
gp22 gp22 5 minutes ago
HEADS UP..$TIRX @ihub_tutorial R/S. Has 300K Total shares & $12.69 cash.. EXACT $HUIZ match.
HUIZ TIRX
Doubledown75 Doubledown75 5 minutes ago
Government wet dream would be for private citizens to sell their metals and buy into the digitized system, whatever it is. I'm pretty sure computers need metals to operate. They need it, it is deemed worthless....they don't need it, it is deemed priceless.  "it" is physical.  The ownership of metals
AABB
swingingRichard swingingRichard 5 minutes ago
I do not recall that. To the best of my knowledge that is the first time I found that dataset at Harvard.
elks elks 5 minutes ago
Hear That added nice pile Today RDAR !!!
RDAR
imjtw2u imjtw2u 5 minutes ago
Im thinking that pep# is going to pass shib in a weeks time. I bought it on a whim, and very happy I did. Up almost 80%....
SHIBUSD
la-tsla-fan la-tsla-fan 5 minutes ago
The CEOP of Tesla, the grossly under estimated ELON, is indeed a genius, SO FAR, his decisions have all panned out.. He is not very good at letting WS analysts know is target dates for "impossible" projects. Instead of asking for schedules and dates, WS analysts should be asking about the possibilit
TSLA
Tally-ho Tally-ho 6 minutes ago
Perhaps I am making way too much sense but crypto stocks are flying right now and this thing can shoot up past a dollar overnight if they borh just bend a little and meet somewhere in the middle, so much more to gain here than there is to lose.
Furthermore, the longer both parties drag this o
NSAV
Hosai Hosai 6 minutes ago
All known upcoming conferences:

Dec 12 - Dr. Audrey Gabelle, Head of Memory Resources and Research Center of Montpellier, will be giving a presentation; Efficacy and safety of blarcamesine (ANAVEX®2-73) in the early stage of Alzheimer's disease: the ANAVEX2-73-AD-004 phase IIb/III stu
AVXL
Dallas-Cowboys Dallas-Cowboys 6 minutes ago
A wonderful day in the neighborhood 
NVDA
gp22 gp22 6 minutes ago
TIRX @ihub_tutorial R/S. Has 300K Total shares & $12.69 cash.. ExACT $HUIZ match.
HUIZ
resx18 resx18 6 minutes ago
The technology can take produced saltwater and turn it into a steam cleaner than most cities tap water by removing most of the metals and suspended solids.$AURI
AURI
threewheeler threewheeler 6 minutes ago
KRTL bidders stacking, super cheap here yet this should be .25-.50s easily
KRTL
fwb fwb 6 minutes ago
During the California Gold Rush
Some struck it rich from finding GOLD
But those that SOLD the PICKS and SHOVELS to those MINERS made out big time.....
What once went around is coming around
NVDA
RobotDroid RobotDroid 6 minutes ago
And the Grift continues with momentum...
NWBO
CashCowMoo CashCowMoo 7 minutes ago
lol thought I would see how CCTL is doing. Not looking too good. I remember buying into this many years ago. Knew it was a risk, but thought maybe it could make a decent flip. Oh well!
CCTL
bluebird50 bluebird50 7 minutes ago
I prefer to ditch the softies....👍🏽
RDAR
rx7171 rx7171 7 minutes ago
It is just for 2023.
AVXL
rx7171 rx7171 7 minutes ago
It is just for 2023.
AVXL
threewheeler threewheeler 7 minutes ago
KRTL bidders stacking, super cheap here yet this should be .25-.50s easily
KRTL

Your Recent History

Delayed Upgrade Clock